Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Roadmap to Global Cystic Fibrosis Care.

Pediatric pulmonology·2025
Same author

Vitamin D status and scholastic achievement in middle age childhood.

Journal of the Egyptian Society of Parasitology·2012
Same author

Language skills and intelligence quotient of protein energy malnutrition survivors.

Journal of tropical pediatrics·2011
Same author

Early detection of protein energy malnutrition in Sharkia Governorate.

The Journal of the Egyptian Public Health Association·2006

Related Experiment Video

Updated: Jul 6, 2026

A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy
10:30

A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy

Published on: May 16, 2015

Neurokinin A level in hypoxic-ischemic encephalopathy.

May F Nassar1, Hoda L El-Sayed, Nermine T Fouad

  • 1Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt. maie_nassar@yahoo.co.uk

Pediatrics International : Official Journal of the Japan Pediatric Society
|March 21, 2008
PubMed
Summary

Neurokinin A (NKA) levels are reduced in neonates with hypoxic-ischemic encephalopathy (HIE), particularly in severe cases. This neurotransmitter may play a role in HIE pathogenesis and its severity.

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Related Experiment Videos

Last Updated: Jul 6, 2026

A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy
10:30

A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy

Published on: May 16, 2015

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Area of Science:

  • Neonatal Neurology
  • Neuroscience
  • Biochemistry

Background:

  • Neonatal hypoxic-ischemic encephalopathy (HIE) is a serious condition affecting newborns.
  • The neurotransmitter neurokinin A (NKA) role in HIE is not fully understood.

Purpose of the Study:

  • To investigate the effect of HIE on NKA levels.
  • To correlate NKA levels with the severity of neonatal hypoxia.

Main Methods:

  • Compared 18 HIE neonates with 10 healthy controls.
  • Measured NKA levels in cord blood and post-stabilization using ELISA.
  • Collected maternal history, delivery details, Apgar scores, and clinical data.

Main Results:

  • NKA levels were significantly lower in HIE neonates at birth compared to controls.
  • NKA levels improved in follow-up samples.
  • Severe hypoxia cases showed the greatest NKA reduction.
  • NKA at birth correlated positively with Apgar scores and HIE stage.

Conclusions:

  • NKA levels are decreased in HIE, with severity correlating to hypoxia degree.
  • NKA may be involved in HIE pathogenesis.
  • HIE disrupts the neonatal central neuropeptide system.